NAMIC 91031303Recalls & reported problems
Navilyst Medical, Inc. · clearaCIL Contrast Injection Line · Class 2
All models of NAMIC (41)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI H965910313030), received between Oct 6, 2017 and Nov 8, 2017 — classified as 2 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
Patient problems
- Air Embolism2
- Low Blood Pressure/ Hypotension1
- No Code Available1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryNov 8, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ANGIODYNAMICS WAS MADE AWARE OF THE EVENT REGARDING A CONTRAST INJECTION LINE VIA VOLUNTARY USER MEDWATCH # MW5072632: "PATIENT WAS HAVING CARDIAC ANGIOGRAM, ALL TUBING AND MEDRAD INJECTION WAS PRIMED AND BACKPRIMED. CONTRAST WAS INJECTED AND PATIENT STARTED TO LOSE BLOOD PRESSURE AND HEART RATE AND THEN CODED. THE PATIENT WAS TAKEN TO ICU. ON REVIEW OF THE CATH FILMS THE NEXT MORNING IT WAS DETERMINED THAT THE PATIENT HAD AN AIR EMBOLISM. THE TUBING THAT HAD BEEN USED DURING THE PROCEDURE HAD BEEN DISCARDED AND THE TEAM WAS NOT ABLE TO INSPECT FOR DAMAGE OR IF CONNECTIONS WERE SEALED AFTER CONTRAST HAD BEEN INJECTED THROUGH THE TUBING. THE INJECTOR WAS REMOVED FROM SERVICE AND CHECKED OUT AND FOUND TO BE WORKING PROPERLY."
Patient problems: Air Embolism
MAUDE report 7011256 ↗InjuryOct 6, 2017Adverse Event Without Identified Device or Use Problem
PT WAS HAVING A CARDIAC ANGIOGRAM, ALL TUBING AND MED RAD INJECTOR WAS PRIMED AND BACK PRIMED. CONTRAST WAS INJECTED AND PT STARTED TO LOSE B/P AND HR AND THEN CODED. THE PATIENT WAS TAKEN TO ICU ON REVIEW OF THE CATH FILMS THE NEXT MORNING, IT WAS DETERMINED THAT THE PATIENT HAD AN AIR EMBOLISM. THE TUBING THAT HAD BEEN USED DURING THE PROCEDURE HAD BEEN DISCARDED AND THE TEAM WAS NOT ABLE TO INSPECT FOR DAMAGE OR IF CONNECTIONS WERE SEALED AFTER CONTRAST HAD BEEN INJECTED THROUGH THE TUBING. THE INJECTOR WAS REMOVED FROM SERVICE AND CHECKED OUT AND FOUND TO BE WORKING PROPERLY.
Patient problems: Air Embolism; Low Blood Pressure/ Hypotension; No Code Available
MAUDE report 6922097 ↗
Other CATHETER, INTRAVASCULAR, DIAGNOSTIC devices
- TrapEase Permanent Vena Cava Filter with the VisEase Angiographic Vessel Dilator 466P306AUCordis Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC6 deaths186 reports
- Dragonfly™ OPTIS™ C408646Lightlab Imaging, Inc. · CATHETER, INTRAVASCULAR, DIAGNOSTIC4 deaths150 reports
- Dragonfly OpStar™ 1014651Lightlab Imaging, Inc. · CATHETER, INTRAVASCULAR, DIAGNOSTIC1 recall87 reports
- LANGSTON IPN913559Teleflex Incorporated · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls14 reports
- Trevo 90238Stryker Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls5 reports
- Expo™ H749085263011Boston Scientific Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls3 reports
- Expo™ H74908526501Boston Scientific Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls1 report
- Expo™ H74908526031Boston Scientific Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page